ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
UBS

UBS (W2LBG4)

0.00
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
0.00
Financial Volume
-
VWAP
-

W2LBG4 Latest News

Actinium Announces FDA Clearance of Iomab-ACT Targeted Conditioning IND Application for Sickle Cell Disease Patients Undergoing Bone Marrow Transplant in Collaboration with Columbia University

Actinium Announces FDA Clearance of Iomab-ACT Targeted Conditioning IND Application for Sickle Cell Disease Patients Undergoing Bone Marrow Transplant in Collaboration with Columbia University PR...

Actinium Pharmaceuticals to Present at the 3rd Annual Targeted Radiopharmaceuticals Summit US

Actinium Pharmaceuticals to Present at the 3rd Annual Targeted Radiopharmaceuticals Summit US PR Newswire NEW YORK, July 25, 2024 Presentation to highlight positive outcomes of Iomab-B led bone...

Actinium Presents First Ever Data Demonstrating Actimab-A in Combination with Leading Menin Inhibitors Leads to Anti-Tumor Control and Potent Leukemic Cell Killing in Preclinical Acute Myeloid Leukemia Models at the 2024 EHA Congress

Actinium Presents First Ever Data Demonstrating Actimab-A in Combination with Leading Menin Inhibitors Leads to Anti-Tumor Control and Potent Leukemic Cell Killing in Preclinical Acute Myeloid...

Actinium Highlights Oral Presentation at EHA 2024 Annual Congress Featuring Improved Outcomes in TP53 Positive Patients Receiving Iomab-B in the Phase 3 SIERRA Trial

Actinium Highlights Oral Presentation at EHA 2024 Annual Congress Featuring Improved Outcomes in TP53 Positive Patients Receiving Iomab-B in the Phase 3 SIERRA Trial PR Newswire NEW YORK, June...

Actinium Announces Results of Actimab-A + CLAG-M Combination Trial Highlighted in Oral Presentation at the 2024 Society of Nuclear Medicine & Molecular Imaging Annual Meeting

Actinium Announces Results of Actimab-A + CLAG-M Combination Trial Highlighted in Oral Presentation at the 2024 Society of Nuclear Medicine & Molecular Imaging Annual Meeting PR Newswire NEW...

Actinium Highlights Mutation Data from the Phase 3 SIERRA Trial of Iomab-B and Novel Linker Technology to Support Solid Tumor Antibody Radiation Conjugate Development at the 2024 Society of Nuclear Medicine & Molecular Imaging Annual Meeting

Actinium Highlights Mutation Data from the Phase 3 SIERRA Trial of Iomab-B and Novel Linker Technology to Support Solid Tumor Antibody Radiation Conjugate Development at the 2024 Society of...

Actinium to Host KOL Webinar to Discuss Iomab-ACT Commercial CAR T-Cell Therapy Trial Design, Objectives and Potential Market Opportunity

Actinium to Host KOL Webinar to Discuss Iomab-ACT Commercial CAR T-Cell Therapy Trial Design, Objectives and Potential Market Opportunity PR Newswire NEW YORK, May 15, 2024 -  KOL and principal...

Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in TP53 Positive Patients at the EHA 2024 Annual Congress and Presentation of Long-Term Efficacy Results in Older Patients Receiving an Iomab-B Led Bone Marrow Transplant in the Phas

Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in TP53 Positive Patients at the EHA 2024 Annual Congress and Presentation of Long-Term Efficacy Results in Older...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
1TMOThermo Fisher Scientific Inc
555.70 €
(12.19%)
18
1AMTAmerican Tower REIT
200.95 €
(12.19%)
73
1CYTHLumen Technologies Inc
1.9002 €
(11.45%)
14.25k
1PYPLPayPal Holdings Inc
59.06 €
(9.03%)
3.61k
1QGENQiagen NV
41.085 €
(6.87%)
100
WTKF24Take Off SpA
0.0015 €
(-40.00%)
20k
WRKT25Roket Sharing Company Spa
0.008 €
(-20.00%)
30k
WGSR24G Rent Spa
0.002 €
(-20.00%)
5k
EPHEPH SpA
0.0162 €
(-17.35%)
417.4k
CMLAAComal AA
0.03 €
(-16.20%)
763.53k
ISPIntesa Sanpaolo Spa
3.783 €
(3.15%)
71.66M
TITTelecom Italia SpA
0.2302 €
(0.79%)
38.48M
RNRisanamento
0.0274 €
(-11.33%)
35.68M
CPRDavide Campari
8.20 €
(-3.53%)
12.29M
SPMSaipem Spa
2.195 €
(-0.14%)
11.23M

Discussion

View Full Feed
al44 al44 1 minute ago
The Biden-Harris Plan to Upend the Constitution

Another leftist crusade driven by hate, fury, envy – and desperation.

by Tim Donner | Jul 30, 2024


It came off almost like a schoolyard taunt from a lame-duck president desperate to restore his tain
Chartmaster Chartmaster 2 minutes ago
Top Bband is at 46 today, pps will be there shortly!
HIRU
QuantumTravesty QuantumTravesty 2 minutes ago
Looks like ASCM and GTSM going naked to slow the rise and collect their shorts.
HIRU
RIGATONI RIGATONI 2 minutes ago
Getting some big volume last few days

ISPO $5.90

looks like a tiny floater
ISPO
Jack_of_All_Trades Jack_of_All_Trades 2 minutes ago
HIRU unleash the BEAST!!!
HIRU
BCM18 BCM18 2 minutes ago
Thank you children! 0008 to 0015 and refilled 0008 to add to my ever growing share count. Wonderful day!

Let's go BLLB!
BLLB
PirateLeviathan8 PirateLeviathan8 2 minutes ago
market cap of 777Mio+
that's crazy and totally utopian at the moment
SERV
Nemesis18 Nemesis18 2 minutes ago
Unlike the lottery, there appears to only be the same NWBO winner every month ?
NWBO
LandPro LandPro 2 minutes ago
25M value is a lie. There is zero value here as it went right back to the trips. Only the stoned or stupid would think differently.
BLLB
trademax42 trademax42 2 minutes ago
Good morning everyone!! Darker shade of green is in the works!! imo
HIRU
tedpeele tedpeele 2 minutes ago
Fool retail once, shame on company. Fool retail twice shame on retail.

The number of times this has happened is in the dozens if not hundreds.

Intentional obfuscation.

They love to report progress - usually in very unclear terms. But they won't tell
LWLG
Monksdream Monksdream 2 minutes ago
Stat: FDA Approves Guardant Colorectal Cancer Screening Test In Big Step For Liquid Biopsy
The Food and Drug Administration on Monday approved a blood test intended to detect colon cancer, a product many experts hope will help catch cases of the disease early enough so that they can be more e
surfkast surfkast 2 minutes ago
BINGO!
Grade D Pumper: A complete idiot, most readers are not convinced he knows anything about stocks in general. The type that says a stock "rocks", but gives no rationale, shows up every so often but no regular schedule.
SPZI
PonkenPlonken PonkenPlonken 2 minutes ago
ATPC excellent alert
ATPC
Gnarlyman Gnarlyman 3 minutes ago
Where did you see the 9/2 date. I had not seen that, but I wasn’t really looking either. Kind of got DD fatigue on this one lately.
AESO
Techroemancer Techroemancer 3 minutes ago
Now you know what it's like arguing with you lmao
MWWC
DJ Ponder DJ Ponder 3 minutes ago
Bwahahahahahahahaha maybe!
Maybe yesterday’s one buck buyer will buy two bucks before the end of the week.
It might trigger a volume alert.
ATMH
Chartmaster Chartmaster 3 minutes ago
Stochastics buy signal alert!!!
HIRU
Art67 Art67 3 minutes ago
come back is happening
DSGT
Myth Myth 3 minutes ago
with a name like " Knuckleheads " it HAS to be a great venue...lol....

enjoy the grandson's visit !
 just Scottie just Scottie 3 minutes ago
Down to 0 next up negative numbers lol
FBEC
linkvest linkvest 3 minutes ago
And again ASCM along with GTSM is walking it down... Keep Slapping this Beast
RDGL
Moonlazer Moonlazer 4 minutes ago
Bumping my all in to 110.09

The second we tap that, I'm loaded for earnings.
NVDA
jour_trader jour_trader 4 minutes ago
Huge spread between b/a as volume wanes. I’d expect volume to pick up a little more leading into the cc even if no news is released.
ELTP
powerbattles powerbattles 4 minutes ago
$ADD .276 13.89% BREAKOUT .25 Uptrend continue $$$$$
ADD